These Analysts Revise Their Forecasts On GH Research After Q1 Results

Benzinga Earnings

05/15

GH Research PLC (NASDAQ:GHRS) reported a wider-than-expected loss for the first quarter on Thursday.

The company posted quarterly losses of 31 cents per share which missed the analyst consensus estimate of losses of 28 cents per share.

“The first quarter of 2026 marks progress as planned toward our global GH001 Phase 3 pivotal program,” said Dr. Velichka Valcheva, Chief Executive Officer.

GH Research shares fell 3.4% to trade at $21.46 on Friday.

These analysts made changes to their price targets on GH Research following earnings announcement.

Citizens analyst Jason N. Butler maintained GH Research with a Market Outperform and lowered the price target from $42 to $39.
Cantor Fitzgerald analyst Charles Duncan maintained the stock with an Overweight rating and raised the price target from $25 to $35.

Considering buying GHRS stock? Here’s what analysts think:

Photo via Shutterstock

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2635035358"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2635035358\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2635035358?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-15 22:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2635035358","market":"hk","top_or_hot":-1,"title":"These Analysts Revise Their Forecasts On GH Research After Q1 Results","media":"Benzinga Earnings","content":"<html><body><p><strong><a href=\"https://laohu8.com/S/GHRS\">GH Research PLC</a></strong> (NASDAQ:GHRS) reported a wider-than-expected loss for the first quarter on Thursday.</p>\n<p>The company posted quarterly losses of 31 cents per share which missed the analyst consensus estimate of losses of 28 cents per share.</p>\n<p>“The first quarter of 2026 marks progress as planned toward our global GH001 Phase 3 pivotal program,” said Dr. Velichka Valcheva, Chief Executive Officer.</p>\n<p>GH Research shares fell 3.4% to trade at $21.46 on Friday.</p>\n<p>These analysts made changes to their price targets on GH Research following earnings announcement.</p>\n<ul>\n<li>Citizens analyst Jason N. Butler maintained GH Research with a Market Outperform and lowered the price target from $42 to $39.</li>\n<li>Cantor Fitzgerald analyst Charles Duncan maintained the stock with an Overweight rating and raised the price target from $25 to $35.</li>\n</ul>\n<p><strong>Considering buying GHRS stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"435\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-1024x435.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-1024x435.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-300x128.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-768x327.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421.png 1277w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These Analysts Revise Their Forecasts On GH Research After Q1 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese Analysts Revise Their Forecasts On GH Research After Q1 Results\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time smaller\">2026-05-15 22:58</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<html><body><p><strong><a href=\"https://laohu8.com/S/GHRS\">GH Research PLC</a></strong> (NASDAQ:GHRS) reported a wider-than-expected loss for the first quarter on Thursday.</p>\n<p>The company posted quarterly losses of 31 cents per share which missed the analyst consensus estimate of losses of 28 cents per share.</p>\n<p>“The first quarter of 2026 marks progress as planned toward our global GH001 Phase 3 pivotal program,” said Dr. Velichka Valcheva, Chief Executive Officer.</p>\n<p>GH Research shares fell 3.4% to trade at $21.46 on Friday.</p>\n<p>These analysts made changes to their price targets on GH Research following earnings announcement.</p>\n<ul>\n<li>Citizens analyst Jason N. Butler maintained GH Research with a Market Outperform and lowered the price target from $42 to $39.</li>\n<li>Cantor Fitzgerald analyst Charles Duncan maintained the stock with an Overweight rating and raised the price target from $25 to $35.</li>\n</ul>\n<p><strong>Considering buying GHRS stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"435\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-1024x435.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-1024x435.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-300x128.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-768x327.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421.png 1277w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GHRS","symbol_name":"GH Research PLC","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/05/52601688/these-analysts-revise-their-forecasts-on-gh-research-after-q1-results","article_id":"2635035358","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2635035358","pubTimestamp":1778857103,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga Earnings","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"GH Research (NASDAQ:GHRS) reported a larger loss than expected in Q1. Analysts lowered price targets, stock fell 3.4%. CEO noted progress in GH001 program.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GHRS":"GH Research PLC","GH":"Guardant Health Inc.","BK4588":"碎股","BK4539":"次新股","BK4585":"ETF&股票定投概念","BK4535":"淡马锡持仓","BK4196":"保健护理服务","BK4007":"制药","BK4551":"寇图资本持仓"},"translate_title":"这些分析师在第一季度业绩公布后修改了对GH Research的预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GHRS":1,"GH":1.5},"content_text":"GH Research PLC (NASDAQ:GHRS) reported a wider-than-expected loss for the first quarter on Thursday.\nThe company posted quarterly losses of 31 cents per share which missed the analyst consensus estimate of losses of 28 cents per share.\n「The first quarter of 2026 marks progress as planned toward our global GH001 Phase 3 pivotal program,」 said Dr. Velichka Valcheva, Chief Executive Officer.\nGH Research shares fell 3.4% to trade at $21.46 on Friday.\nThese analysts made changes to their price targets on GH Research following earnings announcement.\n\nCitizens analyst Jason N. Butler maintained GH Research with a Market Outperform and lowered the price target from $42 to $39.\nCantor Fitzgerald analyst Charles Duncan maintained the stock with an Overweight rating and raised the price target from $25 to $35.\n\nConsidering buying GHRS stock? Here’s what analysts think:\n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}